MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MYTE - US55406W1036 - ADR
7.64 USD
-0.2 (-2.55%)
Taking everything into account, MYTE scores 4 out of 10 in our fundamental rating. MYTE was compared to 123 industry peers in the Specialty Retail industry. While MYTE seems to be doing ok healthwise, there are quite some concerns on its profitability. MYTE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
MYTE had negative earnings in 4 of the past 5 years.
In multiple years MYTE reported negative operating cash flow during the last 5 years.
1.2 Ratios
MYTE has a Return On Assets of -5.01%. This is in the lower half of the industry: MYTE underperforms 68.85% of its industry peers.
The Return On Equity of MYTE (-8.64%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.05%, MYTE is not doing good in the industry: 63.93% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROIC | 0.05% |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of MYTE (0.03%) is worse than 63.93% of its industry peers.
MYTE has a Gross Margin of 47.04%. This is in the better half of the industry: MYTE outperforms 72.13% of its industry peers.
MYTE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
MYTE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MYTE has more shares outstanding than it did 1 year ago.
MYTE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYTE has an improved debt to assets ratio.
2.2 Solvency
MYTE has an Altman-Z score of 4.23. This indicates that MYTE is financially healthy and has little risk of bankruptcy at the moment.
MYTE has a Altman-Z score of 4.23. This is amongst the best in the industry. MYTE outperforms 86.07% of its industry peers.
MYTE has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MYTE (0.19) is better than 61.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.23 |
ROIC/WACC0.01
WACC7.41%
2.3 Liquidity
A Current Ratio of 1.78 indicates that MYTE should not have too much problems paying its short term obligations.
MYTE has a Current ratio of 1.78. This is in the better half of the industry: MYTE outperforms 76.23% of its industry peers.
MYTE has a Quick Ratio of 1.78. This is a bad value and indicates that MYTE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.22, MYTE is doing worse than 85.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 525.00% over the past year.
MYTE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.84%.
The Revenue has been growing by 17.27% on average over the past years. This is quite good.
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
3.2 Future
The Earnings Per Share is expected to grow by 54.63% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 27.29 indicates a quite expensive valuation of MYTE.
MYTE's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MYTE to the average of the S&P500 Index (25.45), we can say MYTE is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 18.32, the valuation of MYTE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MYTE is valued a bit cheaper than 61.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MYTE to the average of the S&P500 Index (34.46), we can say MYTE is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYTE indicates a slightly more expensive valuation: MYTE is more expensive than 67.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 49.69 |
4.3 Compensation for Growth
MYTE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYTE's earnings are expected to grow with 54.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y115.23%
EPS Next 3Y54.63%
5. Dividend
5.1 Amount
MYTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:MYTE (4/30/2025, 8:23:38 PM)
7.64
-0.2 (-2.55%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change10.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Revenue(TTM)880.73M
Net Income(TTM)-35.85M
Analysts76.36
Price Target10.71 (40.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)49.57%
EPS NQ rev (1m)-140.01%
EPS NQ rev (3m)-111.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.95%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.29 | ||
| Fwd PE | 18.32 | ||
| P/S | 1.05 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.23 | ||
| P/tB | 3.57 | ||
| EV/EBITDA | 49.69 |
EPS(TTM)0.28
EY3.66%
EPS(NY)0.42
Fwd EY5.46%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS7.27
BVpS3.42
TBVpS2.14
PEG (NY)0.09
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.01% | ||
| ROE | -8.64% | ||
| ROCE | 0.06% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.05% | ||
| ROICexgc | 0.07% | ||
| OM | 0.03% | ||
| PM (TTM) | N/A | ||
| GM | 47.04% | ||
| FCFM | N/A |
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 47.13% | ||
| Cap/Sales | 1.02% | ||
| Interest Coverage | 0.05 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | 4.23 |
F-Score3
WACC7.41%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.35%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%
MYT NETHERLANDS PARENT BV / MYTE FAQ
What is the ChartMill fundamental rating of MYT NETHERLANDS PARENT BV (MYTE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to MYTE.
Can you provide the valuation status for MYT NETHERLANDS PARENT BV?
ChartMill assigns a valuation rating of 3 / 10 to MYT NETHERLANDS PARENT BV (MYTE). This can be considered as Overvalued.
How profitable is MYT NETHERLANDS PARENT BV (MYTE) stock?
MYT NETHERLANDS PARENT BV (MYTE) has a profitability rating of 2 / 10.
How financially healthy is MYT NETHERLANDS PARENT BV?
The financial health rating of MYT NETHERLANDS PARENT BV (MYTE) is 4 / 10.
Can you provide the expected EPS growth for MYTE stock?
The Earnings per Share (EPS) of MYT NETHERLANDS PARENT BV (MYTE) is expected to grow by 291% in the next year.